Join us for the webinar "Hot Topics in Asthma 2025," a collaborative event presented by ATS, CHEST, SEPAR, ERS, and ALAT, as part of ALAT’s Asthma Week and endorsed by FIRS. This live webinar will feature leading experts discussing the latest developments in asthma management, including eosinophil blood counts, the differences between control and remission, the role of triple therapy before biologics, the future of inhaled biologics, and the use of biologics in non-severe asthma. Supported by: Sanofi
Date and Time: May 5, 2025 | 7:30 PM – 9:00 PM (Central Time)
Languages: Live translation available (English-Spanish / Spanish-English)
Cost: Free and open to everyone, including non-members
Program Highlights:
EOS blood count: does it really matter? – Carlos Celis
Control vs Remission: what’s the difference? – Fernando Holguin
Is triple therapy a necessary step before Biologics? – Sandhya Khurana
Will inhaled biologics be the future of asthma management? – Mariana Muñoz Esquerre
Is there any place for biologics in non-severe asthma? – To be confirmed
Q&A session with all speakers
Don't miss this opportunity to stay at the forefront of asthma care innovation!
